In barely nine months, the pandemic known as COVID‐19 has spread over 200 countries,
affecting more than 22 million people and causing over than 786 000 deaths. Elderly people …

Chronic obstructive pulmonary disease (COPD) is the third leading cause of death
worldwide. In this review, we present the clinical spectrum and pathogenesis of syndromes …

Clinical trials evaluating the management of acute exacerbations of COPD assess
heterogeneous outcomes, often omitting those that are clinically relevant or more important …

Chronic obstructive pulmonary disease (COPD) is a chronic obstructive respiratory disease
characterized by irreversible airway limitation and persistent respiratory symptoms. The …

Introduction Viruses are detected in over 50% of acute asthma attacks and in a notable
proportion of patients with asthma during stable disease state They are associated with …

Exacerbations of chronic obstructive pulmonary disease (COPD) are episodes of acute
worsening of respiratory symptoms that require additional therapy. These events play a …

A recently published ERS core outcome set recommends that all trials of COPD
exacerbation management should assess the treatment success (or “cure” of the …

Testing serum C‐reactive protein (CRP) levels can help determine whether there is a need
for antibiotics and can limit prescribing of antibiotics for illnesses that are likely viral or non …

Objective. To explore the effect of respiration training‐assisted western medicine therapy on
activity tolerance, pulmonary function, and quality of life (QOL) of chronic obstructive …

Amaç: Kronik obstrüktif akciğer hastalığı (KOAH) olan hastalar koronavirüs hastalığı-2019
(COVID-19) mortalitesi açısından yüksek riske sahiptir. Bu risk, eşlik eden diğer hastalıkların …